Preubiquitinated chimeric ErbB2 is constitutively endocytosed and subsequently degraded in lysosomes

Experimental Cell Research

Volumn 319, Issue 3, 2013, Pages 32-45

  Vuong, Tram Thu ^a   Berger, Christian ^b   Bertelsen, Vibeke ^a   Rødland, Marianne Skeie ^a   Stang, Espen ^b   Madshus, Inger Helene ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Clathrin; Endocytosis; ErbB2; Kinase activity; Ubiquitination

Indexed keywords

CLATHRIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2 UB4; EPSIN; EPSIN1; EPSIN15; HYBRID PROTEIN; LYSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CHIMERA; CONTROLLED STUDY; DOWN REGULATION; ENDOCYTOSIS; ENDOSOME; ENZYME ACTIVITY; GENE OVEREXPRESSION; INTERNALIZATION; LYSOSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MOTIF; SWINE; UBIQUITINATION; WESTERN BLOTTING;

EID: 84872425583     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.10.010     Document Type: Article

References (38)

1. Citri A., Yarden Y. EGF-ERBB signaling: towards the systems level. Nat. Rev. Mol. Cell Biol. 2006, 7:505-516.
2. Junttila T.T., Akita R.W., Parsons K., Fields C., Lewis Phillips G.D., Friedman L.S., Sampath D., Sliwkowski M.X. Ligand-independent HER2/HER3/PI3K complex is disrupted by trastuzumab and is effectively inhibited by the PI3K inhibitor GDC-0941. Cancer Cell 2009, 15:429-440.
3. Slamon D.J., Godolphin W., Jones L.A., Holt J.A., Wong S.G., Keith D.E., Levin W.J., Stuart S.G., Udove J., Ullrich A., Press M.F. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989, 244:707-712.
4. Cohen J.A., Weiner D.B., More K.F., Kokai Y., Williams W.V., Maguire H.C., LiVolsi V.A., Greene M.I. Expression pattern of the neu (NGL) gene-encoded growth factor receptor protein (p185neu) in normal and transformed epithelial tissues of the digestive tract. Oncogene 1989, 4:81-88.
5. Mao W., Irby R., Coppola D., Fu L., Wloch M., Turner J., Yu H., Garcia R., Jove R., Yeatman T.J. Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential. Oncogene 1997, 15:3083-3090.
6. Muthuswamy S.K. Trastuzumab resistance: all roads lead to SRC. Nat. Med. 2011, 17:416-418.
7. Haslekas C., Breen K., Pedersen K.W., Johannessen L.E., Stang E., Madshus I.H. The inhibitory effect of ErbB2 on epidermal growth factor-induced formation of clathrin-coated pits correlates with retention of epidermal growth factor receptor-ErbB2 oligomeric complexes at the plasma membrane. Mol. Biol. Cell 2005, 16:5832-5842.
8. Hommelgaard A.M., Lerdrup M., van Deurs B. Association with membrane protrusions makes ErbB2 an internalization-resistant receptor. Mol. Biol. Cell 2004, 15:1557-1567.
9. Sorkin A., Di Fiore P.P., Carpenter G. The carboxyl terminus of epidermal growth factor receptor/erbB-2 chimerae is internalization impaired. Oncogene 1993, 8:3021-3028.
10. Hughes J.B., Berger C., Rodland M.S., Hasmann M., Stang E., Madshus I.H. Pertuzumab increases epidermal growth factor receptor down-regulation by counteracting epidermal growth factor receptor-ErbB2 heterodimerization. Mol. Cancer Ther. 2009, 8:1885-1892.
11. Baselga J., Swain S.M. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat. Rev. Cancer 2009, 9:463-475.
12. Xu W., Mimnaugh E., Rosser M.F., Nicchitta C., Marcu M., Yarden Y., Neckers L. Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90. J. Biol. Chem. 2001, 276:3702-3708.
13. Xu W., Mimnaugh E.G., Kim J.S., Trepel J.B., Neckers L.M. Hsp90, not Grp94, regulates the intracellular trafficking and stability of nascent ErbB2. Cell Stress Chaperones 2002, 7:91-96.
14. Lerdrup M., Hommelgaard A.M., Grandal M., van Deurs B. Geldanamycin stimulates internalization of ErbB2 in a proteasome-dependent way. J. Cell. Sci. 2006, 119:85-95.
15. Pedersen N.M., Madshus I.H., Haslekas C., Stang E. Geldanamycin-induced down-regulation of ErbB2 from the plasma membrane is clathrin dependent but proteasomal activity independent. Mol. Cancer Res. 2008, 6:491-500.
16. Tikhomirov O., Carpenter G. Geldanamycin induces ErbB-2 degradation by proteolytic fragmentation. J. Biol. Chem. 2000, 275:26625-26631.
17. Biamonte M.A., Van de Water R., Arndt J.W., Scannevin R.H., Perret D., Lee W.C. Heat shock protein 90: inhibitors in clinical trials. J. Med. Chem. 2010, 53:3-17.
18. Neckers L. Heat shock protein 90: the cancer chaperone. J. Biosci. 2007, 32:517-530.
19. Mimnaugh E.G., Chavany C., Neckers L. Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin. J. Biol. Chem. 1996, 271:22796-22801.
20. Ehrlich E.S., Wang T., Luo K., Xiao Z., Niewiadomska A.M., Martinez T., Xu W., Neckers L., Yu X.F. Regulation of Hsp90 client proteins by a Cullin5-RING E3 ubiquitin ligase. Proc. Natl. Acad. Sci. USA 2009, 106:20330-20335.
21. Xu W., Marcu M., Yuan X., Mimnaugh E., Patterson C., Neckers L. Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/Neu. Proc. Natl. Acad. Sci. USA 2002, 99:12847-12852.
22. Zhou P., Fernandes N., Dodge I.L., Reddi A.L., Rao N., Safran H., DiPetrillo T.A., Wazer D.E., Band V., Band H. ErbB2 degradation mediated by the co-chaperone protein CHIP. J. Biol. Chem. 2003, 278:13829-13837.
23. Lerdrup M., Bruun S., Grandal M.V., Roepstorff K., Kristensen M.M., Hommelgaard A.M., van Deurs B. Endocytic down-regulation of ErbB2 is stimulated by cleavage of its C-terminus. Mol. Biol. Cell 2007, 18:3656-3666.
24. Bertelsen V., Sak M.M., Breen K., Rodland M.S., Johannessen L.E., Traub L.M., Stang E., Madshus I.H. A chimeric pre-ubiquitinated EGF receptor is constitutively endocytosed in a clathrin-dependent, but kinase-independent manner. Traffic 2011, 12:507-520.
25. Kazazic M., Bertelsen V., Pedersen K.W., Vuong T.T., Grandal M.V., Rodland M.S., Traub L.M., Stang E., Madshus I.H. Epsin 1 is involved in recruitment of ubiquitinated EGF receptors into clathrin-coated pits. Traffic 2009, 10:235-245.
26. Huang F., Khvorova A., Marshall W., Sorkin A. Analysis of clathrin-mediated endocytosis of epidermal growth factor receptor by RNA interference. J. Biol. Chem. 2004, 279:16657-16661.
27. Arvan P., Zhao X., Ramos-Castaneda J., Chang A. Secretory pathway quality control operating in Golgi, plasmalemmal, and endosomal systems. Traffic 2002, 3:771-780.
28. Guerriero C.J., Brodsky J.L. The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology. Physiol. Rev. 2012, 92:537-576.
29. Hirsch C., Gauss R., Horn S.C., Neuber O., Sommer T. The ubiquitylation machinery of the endoplasmic reticulum. Nature 2009, 458:453-460.
30. Okiyoneda T., Apaja P.M., Lukacs G.L. Protein quality control at the plasma membrane. Curr. Opin. Cell Biol. 2011, 23:483-491.
31. Pelham H.R. Membrane traffic: GGAs sort ubiquitin. Curr. Biol. 2004, 14:R357-R359.
32. Acconcia F., Sigismund S., Polo S. Ubiquitin in trafficking: the network at work. Exp. Cell Res. 2009, 315:1610-1618.
33. Roepstorff K., Grovdal L., Grandal M., Lerdrup M., van Deurs B. Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer. Histochem. Cell Biol. 2008, 129:563-578.
34. Sorkin A., Goh L.K. Endocytosis and intracellular trafficking of ErbBs. Exp. Cell Res. 2009, 315:683-696.
35. Solit D.B., Zheng F.F., Drobnjak M., Munster P.N., Higgins B., Verbel D., Heller G., Tong W., Cordon-Cardo C., Agus D.B., Scher H.I., Rosen N. 17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts. Clin. Cancer Res. 2002, 8:986-993.
36. Austin C.D., De Maziere A.M., Pisacane P.I., van Dijk S.M., Eigenbrot C., Sliwkowski M.X., Klumperman J., Scheller R.H. Endocytosis and sorting of ErbB2 and the site of action of cancer therapeutics trastuzumab and geldanamycin. Mol. Biol. Cell 2004, 15:5268-5282.
37. Raiborg C., Stenmark H. The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature 2009, 458:445-452.
38. Zhou P., Fernandes N., Dodge I.L., Reddi A.L., Rao N., Safran H., DiPetrillo T.A., Wazer D.E., Band V., Band H. ErbB2 degradation mediated by the co-chaperone protein CHIP. J. Biol. Chem. 2003, 278:13829-13837.